Format

Send to

Choose Destination
Clin Mol Hepatol. 2015 Sep;21(3):212-9. doi: 10.3350/cmh.2015.21.3.212. Epub 2015 Sep 30.

Managing alcoholic liver disease.

Author information

1
Gastroenterology Research Unit, Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Abstract

Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management of this condition, although specific roles for liver biopsy still remain particularly in the setting of alcoholic hepatitis. Despite a large number of recent treatment trials, the ideal pharmacotherapy approach remains undefined. Most essential is the supportive care and focus on abstinence and nutrition. Owing in part to a great deal of attention from governmental funding sources, a number of new treatment approaches are undergoing rigorous evaluation, hopefully providing future treatment options in this very severe condition.

KEYWORDS:

Alcohol; Alcoholic hepatitis; Corticosteroids; Liver transplantation

PMID:
26523266
PMCID:
PMC4612281
DOI:
10.3350/cmh.2015.21.3.212
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Publishing M2Community Icon for PubMed Central
Loading ...
Support Center